Skip to product information
1 of 1

CHMFL-PI3KD-317 [CAS 2244992-76-3]

CHMFL-PI3KD-317 [CAS 2244992-76-3]

Size

SKU:QM-0137586-01

£401.13 GBP
Sale Sold out
Quantity

Request quote or documents

View full details
  • Description

    CHMFL-PI3KD-317 is a highly potent, selective and orally active PI3Kδ inhibitor, with an IC50 of 6 nM, and exhibits over 10-1500 fold selectivity over other class I, II and III PIKK family isoforms, such as PI3Kα (IC50, 62.6 nM), PI3Kβ (IC50, 284 nM), PI3Kγ (IC50, 202.7 nM), PIK3C2A (IC50, >10000 nM), PIK3C2B (IC50, 882.3 nM), VPS34 (IC50, 1801.7 nM), PI4KIIIA (IC50, 574.1 nM) and PI4KIIIB (IC50, 300.2 nM) . CHMFL-PI3KD-317 inhibits PI3Kδ-mediated Akt T308 phosphorylation in Raji cells, with an EC50 of 4.3 nM. CHMFL-PI3KD-317 has antiproliferative effects on cancer cells[1].

  • CAS Number

    [2244992-76-3]

  • Molecular Formula

    C21H24ClN5O3S2

  • Molecular Weight

    494.03

  • Smiles

    ClC1=C(NS(=O)(C2=CC(C)=CC=C2)=O)C=C(C3=C(C)N=C(NC([C@H](C(C)C)N)=O)S3)C=N1

  • Target

    PI3K

  • Isoform

    PI3KC2β; PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ; Vps34

  • Purity

    98.04

  • Solubility

    DMSO : 250 mg/mL (ultrasonic)

  • Storage Conditions

    -20°C, 3 years (Powder)

  • Shipping Conditions

    Blue Ice

Your cart
Variant Variant total Quantity Price Variant total
5 mgQM-0137586-01
5 mgQM-0137586-01
£401.13/ea
£0.00
£401.13/ea £0.00
10 mM - 1 mLQM-0137586-02
10 mM - 1 mLQM-0137586-02
£431.51/ea
£0.00
£431.51/ea £0.00
10 mgQM-0137586-03
10 mgQM-0137586-03
£577.31/ea
£0.00
£577.31/ea £0.00
25 mgQM-0137586-04
25 mgQM-0137586-04
£998.91/ea
£0.00
£998.91/ea £0.00
50 mgQM-0137586-05
50 mgQM-0137586-05
£1,473.98/ea
£0.00
£1,473.98/ea £0.00
100 mgQM-0137586-06
100 mgQM-0137586-06
£2,032.88/ea
£0.00
£2,032.88/ea £0.00

View cart
0

Total items

£0.00

Product subtotal

Taxes, discounts and shipping calculated at checkout.
View cart

CHMFL-PI3KD-317 [CAS 2244992-76-3]

CHMFL-PI3KD-317 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.